Madeleine Armstrong· @ByMadeleineA · X·· 21 小时前评分45
正文 · 机器翻译
$PFE 的 CDK4i atirmociclib 在 #ESMO26 公布的乳腺癌 2L 治疗结果……该适应证已不再是重点（目前的重点是 1L）。使用 atirmo 后发生一例治疗相关死亡，死因为肺炎。https://www.apexonco.com/pfizer-touts-atirmociclib-success
205 浏览 · 1 赞 · 1 转发 · 0 回复
会议摘要
1842O按 Proffered paper 2: Breast cancer, early and advanced stage 对上
Efficacy and safety of atirmociclib (ATI) + fulvestrant (FUL) in patients (pts) with HR+/HER2– advanced/metastatic breast cancer (mBC) who progressed on prior CDK4/6 inhibitor (CDK4/6i) in a randomized phase 2 study (FOURLIGHT-1)
https://esmocongress.esmo.org来源：Madeleine Armstrong · x.com